Point-of-Care Rapid Tests

6 Items

Set Descending Direction
  1. Only medical facilities
    Calprotectin Schnelltest
    Calprotectin Schnelltest
    €145.00
    Excl. 19% VAT , excl. Shipping Cost
  2. Only medical facilities
    BIOMED C. difficile Toxin A/B + GDH Schnelltest
    C. difficile Toxin A/B + GDH Test
    €265.00
    Excl. 19% VAT , excl. Shipping Cost
  3. Only medical facilities
    BIOMED Rota-Adeno-Norovirus Rapid Test for rotavirus, adenovirus and norovirus GI/GII detection
    Rota-Adeno-Norovirus Test
    €230.00
    Excl. 19% VAT , excl. Shipping Cost
  4. Only medical facilities
    BIOMED Rota-Adenovirus Schnelltest zum Nachweis von Rotavirus und Adenovirus
    Rota-Adenovirus Test
    €85.00
    Excl. 19% VAT , excl. Shipping Cost
  5. Only medical facilities
    RSV Test
    RSV Test
    €114.64
    Excl. 19% VAT , excl. Shipping Cost
  6. Only medical facilities
    BIOMED Influenza A+B Rapid Test with external positive control
    Influenza A+B Test
    €75.00
    Excl. 19% VAT , excl. Shipping Cost
per page

Point-of-Care Rapid Tests for Fast Clinical Diagnostics

Rapid diagnostic information plays a crucial role in modern healthcare. Point-of-Care Rapid Tests enable healthcare professionals to obtain clinically relevant results directly at the site of patient care without the need for dedicated analytical instrumentation. Their ease of use, short turnaround time and straightforward workflow make them a valuable addition to routine diagnostic procedures in a wide range of healthcare settings.

Unlike instrument-based Point-of-Care analyzers, these rapid tests operate independently of analytical devices and provide immediate diagnostic information using ready-to-use test formats. They are designed to support clinical assessment while complementing laboratory diagnostics whenever rapid results are required.

What are Point-of-Care Rapid Tests?

Point-of-Care Rapid Tests are device-independent diagnostic assays that can be performed close to the patient without specialized laboratory equipment. Depending on the specific assay, they detect infectious agents or clinically relevant biomarkers directly from patient specimens using established rapid testing technologies.

Their simple workflow allows healthcare professionals to perform testing efficiently in hospitals, physician offices, emergency departments, outpatient clinics and other decentralized healthcare environments.

By providing rapid diagnostic information within minutes, Point-of-Care Rapid Tests support timely clinical decision-making while reducing delays associated with centralized laboratory testing.

Rapid Tests for Respiratory Infections

Respiratory tract infections remain among the most common causes of medical consultations worldwide. Particularly during seasonal outbreaks, rapid differentiation between common respiratory pathogens supports patient management, infection control measures and further diagnostic planning.

BIOMED offers device-independent rapid tests for important respiratory pathogens, including:

These assays provide rapid qualitative detection and are intended to support healthcare professionals during the initial evaluation of patients presenting with respiratory symptoms. Test results should always be interpreted alongside clinical findings and, where appropriate, confirmed by additional laboratory or microbiological investigations.

Rapid Tests for Gastrointestinal Diagnostics

Gastrointestinal disorders require different diagnostic approaches depending on the underlying clinical presentation. While infectious gastroenteritis requires reliable pathogen detection, inflammatory bowel diseases often rely on biomarker analysis to support differential diagnosis.

BIOMED offers rapid tests for several clinically important gastrointestinal pathogens, including:

These rapid assays support the timely detection of common gastrointestinal pathogens and may assist healthcare professionals in selecting appropriate diagnostic and infection control measures.

The product portfolio is further complemented by the Calprotectin Rapid Test, which serves a fundamentally different diagnostic purpose. Rather than detecting infectious organisms, fecal calprotectin is an established biomarker of intestinal inflammation and supports the assessment of inflammatory bowel diseases. This distinction makes calprotectin testing an important component of gastrointestinal diagnostics beyond infectious disease testing.

By combining infectious disease assays with inflammatory marker testing, BIOMED provides a comprehensive range of device-independent Point-of-Care Rapid Tests for gastrointestinal diagnostics.

Typical Applications

Point-of-Care Rapid Tests are widely used in healthcare environments where rapid diagnostic information is essential.

Typical applications include:

  • Hospitals
  • Emergency Departments
  • Physician Offices
  • Outpatient Clinics
  • Medical Laboratories
  • Gastroenterology Practices
  • Pediatric Healthcare
  • Long-Term Care Facilities

Rapid test results support patient assessment, diagnostic workflows and infection control strategies while complementing comprehensive laboratory investigations.

Advantages of Device-Independent Rapid Tests

Device-independent Point-of-Care Rapid Tests offer several practical advantages for healthcare professionals:

  • No analyzer required
  • Fast results within minutes
  • Simple testing workflow
  • Ready-to-use test formats
  • Suitable for decentralized healthcare settings
  • Easy integration into routine clinical practice

Their ease of implementation makes them particularly valuable wherever immediate diagnostic information is required.

Device-Independent Rapid Tests vs. Instrument-Based POCT

Although both approaches belong to Point-of-Care Testing, they address different clinical requirements.

Device-independent rapid tests provide qualitative or semi-quantitative results without requiring analytical instruments, making them ideal for rapid screening and initial diagnostic assessment.

Instrument-based Point-of-Care analyzers, in contrast, deliver quantitative laboratory measurements using dedicated analytical systems and are primarily used when precise biomarker quantification is required for diagnosis, monitoring or therapeutic decision-making.

Together, both technologies complement each other within modern Point-of-Care diagnostics.

Why Choose BIOMED?

BIOMED offers a carefully selected portfolio of Point-of-Care Rapid Tests covering respiratory infections, gastrointestinal pathogens and inflammatory biomarkers.

The combination of reliable rapid assays, straightforward workflows and products specifically selected for professional healthcare applications enables laboratories, hospitals and physician offices to integrate rapid diagnostics efficiently into their daily routine.

Frequently Asked Questions

What are Point-of-Care Rapid Tests?

Point-of-Care Rapid Tests are device-independent diagnostic assays that provide rapid results directly at the site of patient care without requiring analytical instruments.

Do these rapid tests require an analyzer?

No. All rapid tests in this category are designed for standalone use and do not require a dedicated Point-of-Care analyzer.

Which clinical applications are covered?

The product portfolio includes rapid tests for respiratory infections, gastrointestinal pathogens and intestinal inflammatory biomarkers such as fecal calprotectin.

How do Point-of-Care Rapid Tests differ from Point-of-Care analyzers?

Rapid tests operate independently of analytical instruments and typically provide qualitative or semi-quantitative results. Instrument-based Point-of-Care analyzers generate quantitative laboratory measurements using dedicated analytical platforms.

are usually dispatched on the same day (no dispatch on Fridays)
Orders placed before 12 noon
are usually dispatched on the same day (no dispatch on Fridays)
in an environmentally friendly box
Refrigerated shipping
in an environmentally friendly box
from 2.000 € Germany-wide
Free shipping
from 2.000 € Germany-wide